0
Lung Cancer |

Malignant Degeneration of a Pulmonary Hamartoma Into a Pulmonary Chondrosarcoma

Elbert Williams, BS; Jerry Pratt, MD
Author and Funding Information

Michigan State University College of Human Medicine - Kalamazoo Campus, Kalamazoo, MI


Chest. 2013;144(4_MeetingAbstracts):632A. doi:10.1378/chest.1703647
Text Size: A A A
Published online

Abstract

SESSION TITLE: Cancer Student/Resident Case Report Posters II

SESSION TYPE: Medical Student/Resident Case Report

PRESENTED ON: Tuesday, October 29, 2013 at 01:30 PM - 02:30 PM

INTRODUCTION: Pulmonary hamartomas (PH) have an incidence of 0.25% making them the most common benign tumor of the lung. The potential for malignant degeneration of PH has been controversial. Multiple case reports present PH degenerating into malignant tumors though these have long been disputed.

CASE PRESENTATION: In November of 2012, a 74-year-old woman with a history of a left lower lobe PH was referred for surgery after a CT scan in May revealed tumor enlargement. CT showed a 6.5 x 5.5 cm, irregularly shaped, partially calcified mass in the left lower lobe. Her nodule was first discovered in 1996 and was diagnosed as a chondroid PH after fine needle aspiration (FNA). She was followed with serial CT scans and underwent a repeat FNA in 2004 again demonstrating a chondroid PH. The patient is a former smoker with a 50-pack year history and COPD. In 2003 she underwent lumpectomy and radiation to the right axilla and chest for right-sided breast cancer. At presentation, the patient complained of infrequent cough, fatigue, and myalgia of her upper extremities. She denied any additional respiratory complaints. She was taken to the operating room and the chest was entered through a lateral thoracotomy. The entire left lower lobe was removed. Frozen section revealed adequate margins. She was discharged on post-operative day 4. Pathology revealed a grade 2 chondrosarcoma (CS). There is no evidence of a coexisting or past bone associated tumor.

DISCUSSION: PH are the most common benign tumor of the lung with an incidence of 0.25%. They are typically found in 40-70 year old patients with a 2:1-4:1 predominance in men and are often discovered incidentally. We present a case of malignant degeneration of a chondroid PH. When evaluating a tumor of this nature, it is important to distinguish between a primary CS, a secondary CS, and a malignant PH. It is unlikely our patient had a primary CS due to a longstanding biopsy proven PH. Our patient has no history of a skeletal CS making metastasis unlikely. The authenticity of malignant degeneration of PH has long been called into question. Basile presents a case of malignant degeneration in a patient who underwent resection of a longstanding clinically silent PH. Several months after surgery, the patient expired and a pleomorphic sarcoma was found on necropsy, supporting the ability of PH to undergo malignant change.

CONCLUSIONS: We present a case of malignant degeneration of a PH into a CS. Though rare, our case provides further support to the malignant degenerative potential of PH.

Reference #1: Guo W, Zhao YP, Jiang YG, Wang RW, Ma Z. Surgical treatment and outcome of pulmonary hamartoma: a retrospective study of 20-year experience. J Exp Clin Cancer Res. 2008;27:8.

Reference #2: Steurer S, Huber M, Lintner F. Dedifferentiated chondrosarcoma of the lung: case report and review of the literature. Clin Lung Cancer. 2007;8(7):439-442.

Reference #3: Basile A, Gregoris A, Antoci B, Romanelli M. Malignant change in a benign pulmonary hamartoma. Thorax. 1989;44:232-233.

DISCLOSURE: The following authors have nothing to disclose: Elbert Williams, Jerry Pratt

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543